Managing diversity in organisations: practitioner and academic perspectives: report from a gender in management special interest group research event

Purpose - This report aims to provide a brief summary of the presentations made by researchers and practitioners at the Gender in Management Special Interest Group’s research event, Managing Diversity in Organisations: Practitioner and Academic Perspectives. Design/methodology/approach - The research seminar was chaired by Dr. Adelina Broadbridge (University of Stirling) and Dr. Gillian Maxwell (Glasgow Caledonian University), and featured five presentations related to diversity in organisations, with a focus on gender issues. Twenty-five delegates were in attendance. Findings - The academic research presented provided empirical evidence that women continue to face barriers to career progress in a number of industry sectors. The industry presentations provided examples of organisational efforts to improve diversity both among staff and customers. Research limitations/implications - More needs to be done to ensure that women enjoy career opportunities equal to those of men in a variety of industry sectors. Even in organisations where women are comparatively well represented, such as professional services firms, research indicates that they are disadvantaged in terms of career development and progress. Originality/value - This session provided a valuable opportunity for practitioners and academics to meet and share information regarding the state of diversity in today’s workplace

All blood, No stool: enterohemorrhagic Escherichia coli O157:H7 infection

Enterohemorrhagic Escherichia coli serotype O157:H7 is a pathotype of diarrheagenic E. coli that produces one or more Shiga toxins, forms a characteristic histopathology described as attaching and effacing lesions, and possesses the large virulence plasmid pO157. The bacterium is recognized worldwide, especially in developed countries, as an emerging food-borne bacterial pathogen, which causes disease in humans and in some animals. Healthy cattle are the principal and natural reservoir of E. coli O157:H7, and most disease outbreaks are, therefore, due to consumption of fecally contaminated bovine foods or dairy products. In this review, we provide a general overview of E. coli O157:H7 infection, especially focusing on the bacterial characteristics rather than on the host responses during infection

Data from: Population genetic structure of serotine bats (Eptesicus serotinus) across Europe and implications for the potential spread of bat rabies (European bat lyssavirus EBLV-1)

Understanding of the movements of species at multiple scales is essential to appreciate patterns of population connectivity and in some cases, the potential for pathogen transmission. The serotine bat (Eptesicus serotinus) is a common and widely distributed species in Europe where it frequently harbours European bat lyssavirus type 1 (EBLV-1), a virus causing rabies and transmissible to humans. In the United Kingdom, it is rare, with a distribution restricted to south of the country and so far the virus has never been found there. We investigated the genetic structure and gene flow of E. serotinus across the England and continental Europe. Greater genetic structuring was found in England compared with continental Europe. Nuclear data suggest a single population on the continent, although further work with more intensive sampling is required to confirm this, while mitochondrial sequences indicate an east–west substructure. In contrast, three distinct populations were found in England using microsatellite markers, and mitochondrial diversity was very low. Evidence of nuclear admixture indicated strong male-mediated gene flow among populations. Differences in connectivity could contribute to the high viral prevalence on the continent in contrast with the United Kingdom. Although the English Channel was previously thought to restrict gene flow, our data indicate relatively frequent movement from the continent to England highlighting the potential for movement of EBLV-1 into the United Kingdom